HomeGeneticsConditionSpastic paraplegia type 15
Back to Condition
Spastic paraplegia type 15
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

Spastic paraplegia type 15

Spastic paraplegia type 15 is a complex genetic disorder characterized by progressive muscle stiffness, paralysis of the lower limbs, and additional neurological and developmental features.

Overview

Spastic paraplegia type 15 is part of a group of genetic disorders known as hereditary spastic paraplegias. These disorders are characterized by progressive muscle stiffness (spasticity) and the development of paralysis of the lower limbs (paraplegia). It is classified as a complex hereditary spastic paraplegia because it involves all four limbs as well as additional features, including abnormalities of the brain. The condition also affects the peripheral nervous system, which connects the brain and spinal cord to muscles and sensory cells.

Symptoms

Symptoms usually become apparent in childhood or adolescence. Common features include:

  • Weak muscle tone (hypotonia)
  • Difficulty walking
  • Intellectual disability
  • Abnormal thinning of the tissue connecting the left and right halves of the brain
  • Loss (atrophy) of nerve cells in the cerebral cortex and cerebellum
  • Numbness, tingling, or pain in the arms and legs (sensory neuropathy)
  • Impairment of the nerves that control movement (motor neuropathy)
  • Exaggerated reflexes (hyperreflexia) of the lower limbs
  • Muscle wasting (amyotrophy)
  • Reduced bladder control
  • Pigmentary maculopathy, an eye condition that impairs vision

Rarely, individuals may experience parkinsonism, which includes tremors, rigidity, and unusually slow movement (bradykinesia). As the condition progresses, many people experience a decline in intellectual ability and require walking aids or wheelchair assistance in adulthood.

Causes

Mutations in the ZFYVE26 gene cause spastic paraplegia type 15. This gene provides instructions for making a protein called spastizin, which is essential for autophagy—the process of recycling worn-out cell parts and unneeded proteins. Mutations often result in a shortened, non-functional protein, leading to the accumulation of unneeded materials within cells, which causes cell dysfunction and death.

Inheritance

This condition is inherited in an autosomal recessive pattern, meaning both copies of the gene in each cell have mutations. Parents of an affected individual typically carry one copy of the mutated gene but do not show signs or symptoms of the condition.

Frequently Asked Questions

Parents may notice a child having difficulty standing or walking, frequent falls, or a noticeable stiffness in the legs. Other clues include a gradual loss of muscle tone, unusual muscle spasms, or a delay in reaching motor milestones such as sitting up or crawling. If these symptoms appear, a pediatric neurologist should be consulted for further evaluation.
Diagnosis typically starts with a detailed family and medical history, followed by a neurological exam. Genetic testing is the definitive step; a blood sample is sent for sequencing of the ZFYVE26 gene. Imaging studies like MRI can help rule out other causes and may show brain abnormalities associated with the condition.
Physical therapy focusing on stretching and strengthening exercises is foundational. Occupational therapy can assist with fine motor skills and daily activities. Pharmacologic options include oral antispasticity agents such as baclofen or tizanidine, and in some cases, intrathecal baclofen pumps are considered. Regular physiotherapy and adaptive equipment (e.g., braces, walkers) can also enhance mobility.
Yes. Maintaining a consistent exercise routine that includes gentle stretching and low-impact activities (like swimming or cycling) can help keep muscles flexible. A balanced diet rich in omega‑3 fatty acids and adequate hydration supports nerve health. Using assistive devices early, such as ankle‑foot orthoses, can prevent contractures and improve walking efficiency. Regular follow‑ups with a neurologist and physical therapist help adjust the plan as the child grows.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA